379. Epidemiology of Antimicrobial Use Among SARS-CoV-2 Positive and Negative Admissions in the US: A Multicenter Evaluation

BACKGROUND: SARS-CoV-2, a novel coronavirus, emerged in Wuhan, China in December of 2019, and became a pandemic. Increases in bacterial/fungal co-infections have occurred during influenza pandemics and early data from this pandemic indicate high utilization of antimicrobial therapy. We compared the...

Descripción completa

Detalles Bibliográficos
Autores principales: Puzniak, Laura A, Bauer, Karri A, Finelli, Lyn, De Anda, Carisa, Moise, Pamela, Yu, Kalvin, Vankeepuram, Latha, Parikh, Prashant, Gupta, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777122/
http://dx.doi.org/10.1093/ofid/ofaa439.574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777122/
http://dx.doi.org/10.1093/ofid/ofaa439.574

Ejemplares similares